Excessive sweating AbobotulinumtoxinA has been approved for the treatment of axillary hyperhidrosis, which cannot be managed by topical agents.
Excessive sweating AbobotulinumtoxinA has been approved for the treatment of axillary hyperhidrosis which cannot be managed by topical agents